Scarica l'app Stockscreener
4.07
17.44%
-0.86
Silexion Therapeutics Corp Borsa (SLXN) Ultime notizie
Silexion Therapeutics announces pricing of $6M public offering - MSN
Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data - Benzinga
Silexion Therapeutics Reveals Positive Preclinical Data for SIL204 - TipRanks
Silexion Therapeutics announces pricing of $6.0 million public offering - MarketScreener
Silexion Therapeutics prices 1.5M shares at $4.00 in public offering - TipRanks
Why Is Silexion Therapeutics Stock (SLXN) Up 190% Today? - TipRanks
Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering - GlobeNewswire
$6M Capital Raise: Clinical-Stage RNAi Cancer Biotech Silexion Prices Share & Warrant Offering at $4.00 - Stock Titan
Silexion shares skyrocket 400% after encouraging pancreatic cancer drug results - MSN
Silexion Therapeutics announces preclinical data on SIL204 - TipRanks
Silexion stock soars 400% after positive pancreatic cancer drug data By Investing.com - Investing.com South Africa
Silexion reports positive preclinical data demonstrating SIL204's reach - MarketScreener
Silexion stock soars 400% after positive pancreatic cancer drug data - Investing.com
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration - The Manila Times
Breakthrough: Cancer Drug Reaches All Major Metastatic SitesSilexion's SIL204 Shows Promise for Fatal Disease - Stock Titan
Can Silexion Therapeutics Corp keep up with sector leadersJuly 2025 Selloffs & Weekly High Return Opportunities - Lancaster City Council
What’s the profit margin of Silexion Therapeutics CorpJuly 2025 Pullbacks & Low Risk Entry Point Guides - Lancaster City Council
Watch for Trend Continuation in Silexion Therapeutics Corp Next WeekJuly 2025 Earnings & Reliable Volume Spike Trade Alerts - beatles.ru
RSI Crosses Above 30 for Silexion Therapeutics Corp Equity Warrant — Reversal in SightChart Signals & Precise Buy Zone Tips - beatles.ru
AI Trend Models Suggest Bounce for Silexion Therapeutics Corp Equity WarrantSell Signal & Low Risk Investment Opportunities - beatles.ru
Is Silexion Therapeutics Corp Equity Warrant subject to activist investor interestJuly 2025 Retail & Smart Investment Allocation Tips - beatles.ru
Technical Bounce Expected in Silexion Therapeutics Corp Next WeekPortfolio Gains Summary & Consistent Income Trade Recommendations - beatles.ru
Live Chart Scan Detects Wedge Pattern in Silexion Therapeutics Corp2025 Geopolitical Influence & Stepwise Entry and Exit Trade Signals - beatles.ru
Is Silexion Therapeutics Corp Equity Warrant meeting your algorithmic filter criteriaWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Why Silexion Therapeutics Corp Equity Warrant is moving todayJuly 2025 Volume & Trade Opportunity Analysis Reports - Newser
Why Silexion Therapeutics Corp is moving today2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
What’s next for Silexion Therapeutics Corp Equity Warrant stock priceJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Applying Wyckoff theory to Silexion Therapeutics Corp stock2025 Price Targets & High Return Stock Watch Alerts - Newser
Signal Recap: Is Silexion Therapeutics Corp Equity Warrant’s growth already priced inInflation Watch & Weekly High Return Forecasts - خودرو بانک
Can Silexion Therapeutics Corp Equity Warrant benefit from deglobalization2025 Volume Leaders & Fast Exit and Entry Strategy Plans - خودرو بانک
What is Silexion Therapeutics Corp Equity Warrant’s book value per shareWeekly Trade Summary & Capital Efficiency Focused Strategies - خودرو بانک
Automated trading signals detected on Silexion Therapeutics Corp Equity WarrantIPO Watch & Expert Curated Trade Ideas - Newser
Earnings Report: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soon2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - خودرو بانک
Is Silexion Therapeutics Corp Equity Warrant’s growth already priced in2025 Market Outlook & Accurate Buy Signal Notifications - خودرو بانک
What recovery options are there for Silexion Therapeutics Corp Equity Warrant2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Silexion selects CRO partner for upcoming KRAS cancer therapy trials By Investing.com - Investing.com Canada
Can Silexion Therapeutics Corp Equity Warrant disrupt its industry2025 Top Decliners & Fast Moving Trade Plans - خودرو بانک
What high frequency data says about Silexion Therapeutics CorpAnalyst Downgrade & Community Consensus Stock Picks - Newser
Will Silexion Therapeutics Corp Equity Warrant see short term momentumGDP Growth & Community Verified Trade Signals - Newser
Silexion Therapeutics Corp Equity Warrant stock prediction for this week2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
Backtesting results for Silexion Therapeutics Corp trading strategies2025 Price Action Summary & Risk Controlled Daily Trade Plans - Newser
Is it time to cut losses on Silexion Therapeutics Corp Equity Warrant2025 Biggest Moves & Community Consensus Picks - Newser
Silexion Therapeutics Announces Selection of Contract - GlobeNewswire
Chart overlay techniques for tracking Silexion Therapeutics CorpWeekly Trade Recap & Weekly Breakout Watchlists - Newser
silexion therapeutics corp equity warrant stock prediction for this weekTrade Analysis Report & Low Drawdown Investment Strategies - Newser
Detecting support and resistance levels for Silexion Therapeutics CorpJuly 2025 Market Mood & Precise Buy Zone Tips - Newser
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonJuly 2025 PostEarnings & Stepwise Trade Signal Guides - خودرو بانک
Silexion Therapeutics Partners with AMS for Clinical Trials - MSN
Silexion Therapeutics CorpPhase 2/3 trials to start in first half of 2026 - MarketScreener
Silexion Therapeutics selects AMS as CRO for SIL204 Phase 2/3 trials - TipRanks
Silexion selects CRO partner for upcoming KRAS cancer therapy trials - Investing.com
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204 - The Manila Times
Silexion Therapeutics Selects Contract Research Organization for Phase 2/3 Clinical Trials of SIL204 - AInvest
97% Cancer Cell Inhibition: Silexion's RNAi Drug SIL204 Advances to Phase 2/3 Trials for KRAS Cancers - Stock Titan
Retail Trends: Why is Silexion Therapeutics Corp stock going upMarket Growth Report & Short-Term Trading Alerts - خودرو بانک
Heatmap analysis for Silexion Therapeutics Corp and competitorsShort Setup & Smart Swing Trading Alerts - Newser
Technical signs of recovery in Silexion Therapeutics Corp2025 Key Highlights & Entry Point Confirmation Alerts - Newser
Silexion Therapeutics Corp stock daily chart insightsJuly 2025 Institutional & Smart Investment Allocation Tips - Newser
Short interest data insights for Silexion Therapeutics CorpVolume Spike & Real-Time Price Movement Reports - Newser
Is Silexion Therapeutics Corp showing signs of accumulationQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
Earnings visualization tools for Silexion Therapeutics Corp2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):